These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 18390985

  • 1. Dual-chamber defibrillators reduce clinically significant adverse events compared with single-chamber devices: results from the DATAS (Dual chamber and Atrial Tachyarrhythmias Adverse events Study) trial.
    Almendral J, Arribas F, Wolpert C, Ricci R, Adragao P, Cobo E, Navarro X, Quesada A, DATAS Steering Committee, DATAS Writing Committee, DATAS Investigators.
    Europace; 2008 May; 10(5):528-35. PubMed ID: 18390985
    [Abstract] [Full Text] [Related]

  • 2. The DATAS rationale and design: a controlled, randomized trial to assess the clinical benefit of dual chamber (DDED) defibrillator.
    Quesada A, Almendral J, Arribas F, Ricci R, Wolpert C, Adragao P, Cobo E, Navarro X, DATAS Investigators.
    Europace; 2004 Mar; 6(2):142-50. PubMed ID: 15018874
    [Abstract] [Full Text] [Related]

  • 3. Long-term follow-up of patients supplied with single-chamber or dual-chamber cardioverter defibrillators.
    Kolb C, Deisenhofer I, Schmieder S, Barthel P, Zrenner B, Karch MR, Schmitt C.
    Pacing Clin Electrophysiol; 2006 Sep; 29(9):946-52. PubMed ID: 16981917
    [Abstract] [Full Text] [Related]

  • 4. Dual-chamber implantable cardioverter defibrillators reduce clinical adverse events related to atrial fibrillation when compared with single-chamber defibrillators: a subanalysis of the DATAS trial.
    Ricci RP, Quesada A, Almendral J, Arribas F, Wolpert C, Adragao P, Zoni-Berisso M, Navarro X, DeSanto T, Grammatico A, Santini M, DATAS study Investigators.
    Europace; 2009 May; 11(5):587-93. PubMed ID: 19401341
    [Abstract] [Full Text] [Related]

  • 5. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
    Wilkoff BL, Dual Chamber and VVI Implantable Defibrillator trial investigators.
    Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277
    [Abstract] [Full Text] [Related]

  • 6. Inappropriate ICD discharges in single-chamber versus dual-chamber devices in the pediatric and young adult population.
    Lawrence D, Von Bergen N, Law IH, Bradley DJ, Dick M, Frias PA, Streiper MJ, Fischbach PS.
    J Cardiovasc Electrophysiol; 2009 Mar; 20(3):287-90. PubMed ID: 19175843
    [Abstract] [Full Text] [Related]

  • 7. Reduction of ventricular tachyarrhythmia by treatment of atrial fibrillation in ICD patients with dual-chamber implantable cardioverter/defibrillators capable of atrial therapy delivery: the REVERT-AF Study.
    Gradaus R, Seidl K, Korte T, Himmrich E, Wieneke H, Schuchert A, Bauer W, Gerss J, Wollmann CG, Borggrefe M, Böcker D.
    Europace; 2007 Jul; 9(7):534-9. PubMed ID: 17440005
    [Abstract] [Full Text] [Related]

  • 8. Analysis of implantable defibrillator longevity under clinical circumstances: implications for device selection.
    Knops P, Theuns DA, Res JC, Jordaens L.
    Pacing Clin Electrophysiol; 2009 Oct; 32(10):1276-85. PubMed ID: 19796344
    [Abstract] [Full Text] [Related]

  • 9. Prevention of inappropriate therapy in implantable cardioverter-defibrillators: results of a prospective, randomized study of tachyarrhythmia detection algorithms.
    Theuns DA, Klootwijk AP, Goedhart DM, Jordaens LJ.
    J Am Coll Cardiol; 2004 Dec 21; 44(12):2362-7. PubMed ID: 15607399
    [Abstract] [Full Text] [Related]

  • 10. The effect of gender on mortality or appropriate shock in patients with nonischemic cardiomyopathy who have implantable cardioverter-defibrillators.
    Chen HA, Hsia HH, Vagelos R, Fowler M, Wang P, Al-Ahmad A.
    Pacing Clin Electrophysiol; 2007 Mar 21; 30(3):390-4. PubMed ID: 17367359
    [Abstract] [Full Text] [Related]

  • 11. Causes and consequences of heart failure after prophylactic implantation of a defibrillator in the multicenter automatic defibrillator implantation trial II.
    Goldenberg I, Moss AJ, Hall WJ, McNitt S, Zareba W, Andrews ML, Cannom DS, Multicenter Automatic Defibrillator Implantation Trial (MADIT) II Investigators.
    Circulation; 2006 Jun 20; 113(24):2810-7. PubMed ID: 16769917
    [Abstract] [Full Text] [Related]

  • 12. Complications leading to surgical revision in implantable cardioverter defibrillator patients: comparison of patients with single-chamber, dual-chamber, and biventricular devices.
    Duray GZ, Schmitt J, Cicek-Hartvig S, Hohnloser SH, Israel CW.
    Europace; 2009 Mar 20; 11(3):297-302. PubMed ID: 19054788
    [Abstract] [Full Text] [Related]

  • 13. Indications for dual-chamber cardioverter defibrillators at implant and at 1 year follow-up: a retrospective analysis in the single-chamber defibrillator era.
    Proclemer A, Della Bella P, Facchin D, Fattore L, Carbucicchio C, Tondo C, Lunati M, Vecchi MR, Petz E, Zecchin M.
    Europace; 2001 Apr 20; 3(2):132-5. PubMed ID: 11333050
    [Abstract] [Full Text] [Related]

  • 14. Severe atrioventricular decoupling, uncoupling, and ventriculoatrial coupling during enhanced atrial pacing: incidence, mechanisms, and implications for minimizing right ventricular pacing in ICD patients.
    Sweeney MO, Ellenbogen KA, Tang AS, Johnson J, Belk P, Sheldon T.
    J Cardiovasc Electrophysiol; 2008 Nov 20; 19(11):1175-80. PubMed ID: 18554192
    [Abstract] [Full Text] [Related]

  • 15. Long-term predictors of mortality in ICD patients with non-ischaemic cardiac disease: impact of renal function.
    Schefer T, Wolber T, Binggeli C, Holzmeister J, Brunckhorst C, Duru F.
    Europace; 2008 Sep 20; 10(9):1052-9. PubMed ID: 18687703
    [Abstract] [Full Text] [Related]

  • 16. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact.
    Daubert JP, Zareba W, Cannom DS, McNitt S, Rosero SZ, Wang P, Schuger C, Steinberg JS, Higgins SL, Wilber DJ, Klein H, Andrews ML, Hall WJ, Moss AJ, MADIT II Investigators.
    J Am Coll Cardiol; 2008 Apr 08; 51(14):1357-65. PubMed ID: 18387436
    [Abstract] [Full Text] [Related]

  • 17. Right ventricular pacing is associated with impaired overall survival, but not with an increased incidence of ventricular tachyarrhythmias in routine cardioverter/defibrillator recipients with reservedly programmed pacing.
    Stockburger M, Celebi O, Krebs A, Knaus T, Nitardy A, Habedank D, Dietz R.
    Europace; 2009 Jul 08; 11(7):924-30. PubMed ID: 19447808
    [Abstract] [Full Text] [Related]

  • 18. The Managed Ventricular pacing versus VVI 40 Pacing (MVP) Trial: clinical background, rationale, design, and implementation.
    Sweeney MO, Ellenbogen KA, Miller EH, Sherfesee L, Sheldon T, Whellan D.
    J Cardiovasc Electrophysiol; 2006 Dec 08; 17(12):1295-8. PubMed ID: 17081208
    [Abstract] [Full Text] [Related]

  • 19. Dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: the detect supraventricular tachycardia study.
    Friedman PA, McClelland RL, Bamlet WR, Acosta H, Kessler D, Munger TM, Kavesh NG, Wood M, Daoud E, Massumi A, Schuger C, Shorofsky S, Wilkoff B, Glikson M.
    Circulation; 2006 Jun 27; 113(25):2871-9. PubMed ID: 16769912
    [Abstract] [Full Text] [Related]

  • 20. Survival and appropriate device interventions in recipients of cardioverter defibrillators implanted for the primary versus secondary prevention of sudden cardiac death.
    Stockburger M, Krebs A, Nitardy A, Habedank D, Celebi O, Knaus T, Dietz R.
    Pacing Clin Electrophysiol; 2009 Mar 27; 32 Suppl 1():S16-20. PubMed ID: 19250084
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.